Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11172162 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada
Condition: Multiple Sclerosis
Interventions: Other: Exposed to Arepanrix™ Cohort;   Other: Unexposed to Arepanrix™ Cohort
2 Completed Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: Bacille of Calmette-Guerin;   Other: placebo

Indicates status has not been verified in more than two years